{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T02:56:25Z","timestamp":1789440985161,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.iac.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T16:55:46Z","timestamp":1574355346000},"page":"69-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma"],"prefix":"10.1016","volume":"40","author":[{"given":"Linda S.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Murphey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Hankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 86","key":"10.1016\/j.iac.2019.09.003_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMcp1412282","article-title":"Clinical practice. Allergic rhinitis","volume":"372","author":"Wheatley","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2019.09.003_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1753465811431975","article-title":"The burden of allergic rhinitis and asthma","volume":"6","author":"Ozdoganoglu","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.iac.2019.09.003_bib4","doi-asserted-by":"crossref","first-page":"vi","DOI":"10.3310\/hta17270","article-title":"A\u00a0systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis","volume":"17","author":"Meadows","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.iac.2019.09.003_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.anai.2013.09.018","article-title":"Environmental assessment and exposure control of dust mites: a practice parameter","volume":"111","author":"Portnoy","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.anai.2012.09.019","article-title":"Environmental assessment and exposure reduction of rodents: a practice parameter","volume":"109","author":"Phipatanakul","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib8","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jaci.2013.04.061","article-title":"Environmental assessment and exposure reduction of cockroaches: a practice parameter","volume":"132","author":"Portnoy","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib9","doi-asserted-by":"crossref","first-page":"223.e1-15","DOI":"10.1016\/j.anai.2012.02.015","article-title":"Environmental assessment and exposure control: a practice parameter\u2013furry animals","volume":"108","author":"Portnoy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1183\/09031936.04.00013904","article-title":"Prevalence and rate of diagnosis of allergic rhinitis in Europe","volume":"24","author":"Bauchau","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2019.09.003_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1398-9995.2007.01367.x","article-title":"Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey","volume":"62","author":"Maurer","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib14","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1185\/03007990902915061","article-title":"Frequency of diagnosis and treatment of allergic rhinitis among adults with asthma in Germany, France, and the UK: National Health and Wellness Survey","volume":"25","author":"Sazonov","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2019.09.003_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.rmed.2005.05.012","article-title":"Unawareness and undertreatment of asthma and allergic rhinitis in a general population","volume":"100","author":"Nolte","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.iac.2019.09.003_bib16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jaci.2012.12.662","article-title":"Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis","volume":"131","author":"Hankin","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib17","first-page":"517","article-title":"Direct and indirect costs associated with respiratory allergic diseases in Italy. A probabilistic cost of illness study","volume":"106","author":"Marcellusi","year":"2015","journal-title":"Recenti Prog Med"},{"key":"10.1016\/j.iac.2019.09.003_bib18","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1542\/peds.2013-2294VV","article-title":"Allergic rhinitis is associated with otitis media with effusion: a birth cohort study","volume":"132","author":"Minto","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.iac.2019.09.003_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.anai.2014.07.025","article-title":"Diagnosis and management of rhinosinusitis: a practice parameter update","volume":"113","author":"Peters","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2500\/aap.2010.31.3329","article-title":"Allergic rhinitis: direct and indirect costs","volume":"31","author":"Blaiss","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.003_bib21","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaci.2009.05.013","article-title":"Burden of allergic rhinitis: results from the Pediatric Allergies in America survey","volume":"124","author":"Meltzer","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.clinthera.2007.02.007","article-title":"Findings from a 1000-patient internet-based survey assessing the impact of morning symptoms on individuals with allergic rhinitis","volume":"29","author":"Long","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.iac.2019.09.003_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2500\/aap2008.29.3072","article-title":"Pediatric allergic rhinitis: physical and mental complications","volume":"29","author":"Blaiss","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.003_bib24","first-page":"297","article-title":"Congestion and sleep impairment in allergic rhinitis","volume":"29","author":"Sardana","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2500\/aap.2009.30.3230","article-title":"Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey","volume":"30","author":"Meltzer","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.003_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MOO.0000000000000150","article-title":"Allergy immunotherapy in reducing healthcare cost","volume":"23","author":"Cox","year":"2015","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.iac.2019.09.003_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2500\/ajra.2016.30.4253","article-title":"The role of allergen immunotherapy in the management of allergic rhinitis","volume":"30","author":"Cox","year":"2016","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1365-2222.2012.04038.x","article-title":"Allergic rhinitis is associated with otitis media with effusion: a birth cohort study","volume":"42","author":"Kreiner-Moller","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ACI.0000000000000084","article-title":"Allergy immunotherapy: what is the evidence for cost saving?","volume":"14","author":"Hankin","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"Suppl 85","key":"10.1016\/j.iac.2019.09.003_bib30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1398-9995.2007.01548.x","article-title":"A\u00a0survey of the burden of allergic rhinitis in the USA","volume":"62","author":"Schatz","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jaip.2015.12.018","article-title":"Allergen immunotherapy for atopic dermatitis: is there room for debate?","volume":"4","author":"Cox","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2019.09.003_bib32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1081-1206(10)60220-7","article-title":"Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology\/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force","volume":"101","author":"Cox","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jaci.2010.12.1080","article-title":"Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies","volume":"127","author":"James","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib35","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1081-1206(10)60211-6","article-title":"Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study","volume":"101","author":"Marogna","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0091-6749(97)70069-1","article-title":"Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children","volume":"99","author":"Des Roches","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study","volume":"126","author":"Marogna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib38","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib39","first-page":"27","article-title":"Economic aspects of sublingual immunotherapy","volume":"22","author":"Incorvaia","year":"2009","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.iac.2019.09.003_bib40","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1081-1206(10)60190-1","article-title":"Economic evaluation of sublingual immunotherapy vs. symptomatic treatment in allergic asthma","volume":"103","author":"Ariano","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 82","key":"10.1016\/j.iac.2019.09.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2006.01219_1.x","article-title":"Standards for practical allergen-specific immunotherapy","volume":"61","author":"Alvarez-Cuesta","year":"2006","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2019.09.003_bib42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM199602223340804","article-title":"Ragweed immunotherapy in adult asthma","volume":"334","author":"Creticos","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2019.09.003_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0301-0546(05)73246-8","article-title":"Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy","volume":"33","author":"Petersen","year":"2005","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.iac.2019.09.003_bib45","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1185\/030079907X187865","article-title":"A\u00a0cost-effectiveness analysis of immunotherapy with SQ allergen extract for patients with seasonal allergic rhinoconjunctivitis in selected European countries","volume":"23","author":"Keiding","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2019.09.003_bib46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jaci.2005.11.014","article-title":"Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis","volume":"117","author":"Frew","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1081-1206(10)60498-X","article-title":"Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma","volume":"101","author":"Bruggenjurgen","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2007.10.026","article-title":"Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs","volume":"121","author":"Hankin","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2009.11.010","article-title":"Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study","volume":"104","author":"Hankin","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00019053-200017010-00003","article-title":"Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany","volume":"17","author":"Schadlich","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.iac.2019.09.003_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/2045-7022-3-30","article-title":"Influence of subcutaneous specific immunotherapy on drug costs in children suffering from allergic asthma","volume":"3","author":"Reinhold","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib52","first-page":"303","article-title":"Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma","volume":"37","author":"Berto","year":"2005","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib53","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jaci.2006.05.003","article-title":"Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis","volume":"118","author":"Dahl","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib54","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2222.2007.02706.x","article-title":"Cost-effectiveness of grass allergen tablet (GRAZAX(R)) for the prevention of seasonal grass pollen induced rhinoconjunctivitis: a Northern European perspective","volume":"37","author":"Bachert","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib55","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.rmed.2007.05.003","article-title":"Cost-effectiveness of GRAZAX for prevention of grass pollen induced rhinoconjunctivitis in Southern Europe","volume":"101","author":"Canonica","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.iac.2019.09.003_bib56","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1398-9995.2008.01743.x","article-title":"Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma","volume":"63","author":"Nasser","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib57","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1081-1206(10)61090-3","article-title":"Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study","volume":"97","author":"Berto","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib58","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1185\/030079908X253726","article-title":"Comparison of costs of sublingual immunotherapy and drug treatment in grass-pollen induced allergy: results from the SIMAP database study","volume":"24","author":"Berto","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2019.09.003_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40261-013-0067-z","article-title":"Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults","volume":"33","author":"Ruggeri","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.iac.2019.09.003_bib60","first-page":"187","article-title":"Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax((R))) in children","volume":"6","author":"Ronaldson","year":"2014","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.iac.2019.09.003_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13601-016-0127-6","article-title":"Cost utility analysis of the SQ((R)) HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting","volume":"6","author":"Hahn-Pedersen","year":"2016","journal-title":"Clinical and translational allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/CEOR.S115931","article-title":"Cost-effectiveness of SQ((R)) HDM SLIT-tablet in addition to pharmacotherapy for the treatment of house dust mite allergic rhinitis in Germany","volume":"9","author":"Green","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.iac.2019.09.003_bib63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1081-1206(10)60475-9","article-title":"Economic evaluation of sublingual vs subcutaneous allergen immunotherapy","volume":"100","author":"Pokladnikova","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2019.09.003_bib64","first-page":"253","article-title":"Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis","volume":"4","author":"Ronborg","year":"2012","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.iac.2019.09.003_bib65","first-page":"906","article-title":"Cost effectiveness analysis of immunotherapy in patients with grass pollen allergic rhinoconjunctivitis in Germany","volume":"15","author":"Westerhout","year":"2012","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.iac.2019.09.003_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jep.12112","article-title":"Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost","volume":"20","author":"Dranitsaris","year":"2014","journal-title":"J\u00a0Eval Clin Pract"},{"key":"10.1016\/j.iac.2019.09.003_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13601-015-0045-z","article-title":"Health economic comparison of SLIT allergen and SCIT allergoid immunotherapy in patients with seasonal grass-allergic rhinoconjunctivitis in Germany","volume":"5","author":"Verheggen","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.iac.2019.09.003_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40629-016-0002-y","article-title":"Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment","volume":"26","author":"Reinhold","year":"2017","journal-title":"Allergo J Int"},{"key":"10.1016\/j.iac.2019.09.003_bib69","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3111\/13696990701438587","article-title":"Influence of time horizon and treatment patterns on cost-effectiveness measures: the case of allergen-specific immunotherapy with Grazax","volume":"10","author":"Beriot-Mathiot","year":"2007","journal-title":"Journal of medical economics"},{"key":"10.1016\/j.iac.2019.09.003_bib70","first-page":"159","article-title":"Pharmacoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma","volume":"27","author":"Ariano","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2019.09.003_bib71","first-page":"148","article-title":"Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France","volume":"39","author":"Omnes","year":"2007","journal-title":"Eur Ann Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856119300657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:48Z","timestamp":1760179368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856119300657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0889856119300657"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cost-Effectiveness of Allergen Immunotherapy Compared with Pharmacotherapy for Treatment of Allergic Rhinitis and Asthma","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}